NCT05158803

Brief Summary

investigate the diagnostic ability of thoracic ultrasound in suspicious COVID-19 infection and/or COVID-19 pneumonia. Also, to compare its findings to CT and follow up these findings.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 15, 2021

Completed
17 days until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

December 15, 2021

Status Verified

December 1, 2021

Enrollment Period

2 years

First QC Date

December 12, 2021

Last Update Submit

December 14, 2021

Conditions

COVID-19

Outcome Measures

Primary Outcomes (1)

  • diagnostic ability of thoracic ultrasound for diagnosis and follow up of covid19 patients

    compare lung ultrasound with C.T finding of covid 19 patients

    after 1 month of acute presentation

Study Arms (2)

covid 19 in acute phase

Radiation: ultrasound and C.T

covid 19 follow up

Radiation: ultrasound and C.T

Interventions

ultrasound and C.TRADIATION

lung ultrasound in comparison to C.T

covid 19 follow upcovid 19 in acute phase

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

covid 19 patients in acute phase and follow up after 1 and 2 months

You may qualify if:

  • all cases of covid 19 patients

You may not qualify if:

  • all other causes of consolidation ,ground glass fibrosis or collapse findings of C.T and ultrasound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sohag university

Study Record Dates

First Submitted

December 12, 2021

First Posted

December 15, 2021

Study Start

January 1, 2022

Primary Completion

January 1, 2024

Study Completion

December 30, 2024

Last Updated

December 15, 2021

Record last verified: 2021-12